Verdane Acquires Majority Stakes in Trifork Labs Portfolio (Axoniq, Dawn Health, Frameo, XCI)
July 16, 2026
Verdane agreed to acquire majority ownership stakes in four technology businesses from Trifork Labs, the R&D/venture arm of Trifork Group. The portfolio includes Axoniq, Dawn Health, Frameo, and XCI, with Verdane acquiring 52% of the combined book value for a total cash consideration of EUR 22.8 million plus earnout payments.
- Buyers
- Verdane
- Targets
- Axoniq B.V., Dawn Holding ApS, Frameo ApS, XCI Holding A/S
- Sellers
- Trifork Group AG
- Industry
- Cybersecurity
- Location
- Switzerland
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.